Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109

9518447302
|
Calling
Whatsapp

Home/All Molecules/Mirtazapine

Mirtazapine Range

Comprehensive Mirtazapine portfolio for Franchise & Manufacturing.

Category
mirtazapine
Total Formulations
4
Available Forms
Tablets
Featured Combinations
Browse by Form
Why Partner with Us?
About Molecule
Franchise FAQ

Expand Your Business with Our Multiple Divisions

General and OTC
Critical Care Injections
Gynae and Infertility care
Respiratory Care
Pediatric Medicines
Derma Care
Neuro care
Eye and Ear care
Ayurvedic Herbal care
Cardiac Diabetic Care
Cardiac Diabetic Care
Cardiac Diabetic Care

Browse Mirtazapine portfolio by Dosage Form

Tablets

The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Mirtazapine batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Mirtazapine PCD Pharma Franchise Company

Mirtazapine PCD Pharma Franchise Company

Cafoli Lifecare is a trusted Mirtazapine PCD pharma franchise company in India, offering a focused range of 4 Mirtazapine formulations manufactured at WHO-GMP certified facilities. We supply consistent, DCGI-approved antidepressant products to franchise partners and distributors who need dependable stock and district-wise monopoly support.

What is Mirtazapine?

Mirtazapine is a tetracyclic noradrenergic and specific serotonergic antidepressant that blocks alpha-2 adrenergic and select serotonin receptors to increase noradrenaline and serotonin signalling. It is used mainly for major depressive disorder. Learn more from the PubChem compound record.

Available Mirtazapine Formulations

Our current Mirtazapine portfolio spans 4 Mirtazapine formulations available in the following forms: Tablets. Every batch is quality tested and released under WHO-GMP controls to ensure uniform quality across supply cycles.

Therapeutic Applications

Mirtazapine is indicated for major depressive disorder, particularly where insomnia or reduced appetite are present. It is prescribed by psychiatrists and mental health physicians and is dispensed strictly on prescription under qualified medical supervision.

Why Mirtazapine is a High-Potential Molecule for Distributors

Depression management is a growing therapy area in India and mirtazapine offers a differentiated sedating profile that many prescribers value, supporting consistent repeat demand.

Why Choose Cafoli Lifecare

Partners receive district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs, and the backing of a network of 1000+ franchise partners across India. Our supply reliability and compliance-first approach help you build a durable Mirtazapine franchise business.

References

  1. PubChem: Mirtazapine
  2. MedlinePlus: Mirtazapine
  3. PubMed: Mirtazapine research

Aceclofenac in Modern Clinical Practice

Our formulations of Mirtazapine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:

FAQ about Mirtazapine in PCD Franchise

Start Your Mirtazapine Franchise with Cafoli Lifecare

Secure district-wise monopoly rights for WHO-GMP certified Mirtazapine formulations. Call 9518447302 or email info@cafoli.in to request your franchise quote today.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

We currently offer 4 Mirtazapine formulations, available as Tablets, all manufactured under WHO-GMP standards.

We grant district-wise monopoly rights so each partner markets Mirtazapine exclusively within their allotted territory.

Mirtazapine is typically recommended by psychiatrists and mental health physicians.

Mirtazapine has a sedating and appetite-stimulating profile, which is why it is often chosen for patients with insomnia or poor appetite. It is prescription-only and psychiatrist supervised.

A valid Drug License and GST registration are required to begin your Mirtazapine franchise with Cafoli Lifecare.

Our Manufacturing Partners

Our Manufacturing Partner | Akums Drugs and Pharmaceuticals
Our Manufacturing Partner | Pharmaceuticals Pvt. Ltd.
Our Manufacturing Partner | Tirupati
Our Manufacturing Partner | Swess-Garniers
Our Manufacturing Partner | Windlas Biotech Limited
Our Manufacturing Partner | Hetero Pharmaceutical company
Our Manufacturing Partner | Unimarck
Our Manufacturing Partner | mascort
Our Manufacturing Partner | Synokem Pharmaceuticals Limited
Our Manufacturing Partner | Biodeal Pharmaceuticals Limited